FDA Says All Off-Label Communications Can Fall Within Regulatory Purview By Sam | January 18, 2017 The First Amendment does not preclude drugmakers from FDA’s oversight of off-label communication even if what they say is truthful. Source: Drug Industry Daily Posted in Drug Industry Daily